Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Shandong Multiple Myeloma Active Trials & Centers
As of 2026-10-21, there are 34 active clinical trials for multiple myeloma hosted across 27 tertiary medical centers in Shandong (including Heze Municipal Hospital, Binzhou Medical University Hospital, Shandong Provincial Hospital, etc.).
Participating Medical Centers (27)
Active Studies in Shandong (34)
Population synthesized by CMDNShowing 0 published English records of 34 registry trials.
All 34 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.
